Health Care & Life Sciences » Pharmaceuticals | Concert Pharmaceuticals Inc.

Concert Pharmaceuticals Inc. | Ownership

Companies that own Concert Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
BVF Partners LP
1,817,138
7.76%
-114,985
1.93%
06/30/2018
BlackRock Fund Advisors
1,502,198
6.42%
93,974
0%
06/30/2018
Ingalls & Snyder LLC
1,337,862
5.71%
15,800
0.93%
06/30/2018
The Vanguard Group, Inc.
1,115,994
4.76%
61,180
0%
06/30/2018
Dimensional Fund Advisors LP
943,442
4.03%
205,796
0%
06/30/2018
Acadian Asset Management LLC
941,282
4.01%
95,863
0.04%
06/30/2018
Northern Trust Investments, Inc.
674,923
2.88%
38,826
0%
06/30/2018
Millennium Management LLC
659,152
2.82%
227,269
0.01%
06/30/2018
Renaissance Technologies LLC
606,400
2.59%
112,200
0.01%
06/30/2018
Franklin Advisers, Inc.
577,035
2.46%
135
0.01%
06/30/2018

About Concert Pharmaceuticals

View Profile
Address
99 Hayden Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.concertpharma.com
Updated 07/08/2019
Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.